Experience of the Eliava Institute in bacteriophage therapy

Virologica Sinica

Volumn 30, Issue 1, 2015, Pages 80-81

  Kutateladze, Mzia ^a  

^a George Eliava Institute of Bacteriophage Microbiology and Virology   (Georgia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE; HUMAN; MICROBIOLOGY; NONHUMAN; VIROLOGY; BACTERIAL INFECTIONS; BACTERIUM; BIOLOGICAL THERAPY; GENETICS; GEORGIA (REPUBLIC); HISTORY; ISOLATION AND PURIFICATION; PHYSIOLOGY;

BACTERIA; BACTERIAL INFECTIONS; BACTERIOPHAGES; BIOLOGICAL THERAPY; GEORGIA (REPUBLIC); HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS;

EID: 84923175543     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-014-3557-0     Document Type: Article

References (5)

1. Alavidze Z, Kutateladze M. Bacteriophage therapy. 2001. New York: Academic Press, pp. 89–92.
2. Kutateladze M, Adamia R. 2008. Medicine et Maladies Infectiouses, 38: 426–430.
3. Kutateladze M, Adamia R. 2010. Trends Biotechnol, 28: 591–595.
4. Fitzgerald-Hughes D, Bolkvadze D, Balarjishvili N, et al. 2014. J Antimicrob Chemoth, 69:1148–1150.
5. Kutter E, Borysowski J, Miedzybrodzki R, et al. Norfolk: Caister Academic Press, pp. 257–288.